Company Filing History:
Years Active: 2025
Title: Shuyong Zhao: Innovator in Cancer Treatment
Introduction
Shuyong Zhao is a prominent inventor based in Shandong, China. He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work focuses on the creation of antibodies that can be used in the diagnosis and treatment of various cancers.
Latest Patents
Shuyong Zhao holds a patent for an "Antibody against claudin 18A2 and use thereof." This patent includes an anti-CLDN18.2 antibody or an antigen-binding fragment thereof, along with derivatives comprising said antibody or antigen-binding fragment. The pharmaceutical composition and related uses of this antibody are aimed at treating, diagnosing, and detecting cancers. He has 1 patent to his name.
Career Highlights
Zhao is associated with Qilu Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research in the pharmaceutical industry. His dedication to improving cancer treatment options has positioned him as a key figure in his field.
Collaborations
Shuyong Zhao collaborates with talented individuals such as Yingying Yang and Gao Li. Their combined expertise enhances the research and development efforts at Qilu Pharmaceutical Co., Ltd.
Conclusion
Shuyong Zhao's innovative work in developing antibodies for cancer treatment showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his patent reflects the potential for significant impact in this critical area of healthcare.